CryoBiopsy
CryoBiopsy: a bi-modal temperature sample preservation device for standardized breast cancer biopsy
Total Cost €
0EC-Contrib. €
0Partnership
0Views
0CryoBiopsy project word cloud
Explore the words cloud of the CryoBiopsy project. It provides you a very rough idea of what is the project "CryoBiopsy" about.
Project "CryoBiopsy" data sheet
The following table provides information about the project.
| Coordinator |
SOREK MEDICAL SYSTEMS LTD
Organization address contact info |
| Coordinator Country | Israel [IL] |
| Project website | http://sorek-medical.com/ |
| Total cost | 71˙429 € |
| EC max contribution | 50˙000 € (70%) |
| Programme |
1. H2020-EU.3.1.3. (Treating and managing disease) |
| Code Call | H2020-SMEINST-1-2016-2017 |
| Funding Scheme | SME-1 |
| Starting year | 2017 |
| Duration (year-month-day) | from 2017-02-01 to 2017-05-31 |
Partnership
Take a look of project's partnership.
| # | ||||
|---|---|---|---|---|
| 1 | SOREK MEDICAL SYSTEMS LTD | IL (YOKNEAM ILLIT) | coordinator | 50˙000.00 |
Map
Project objective
Biopsy is commonly used in medicine and clinical research for diagnosis and characterization of cancer and other diseases. Traditionally, the tissue sample obtained is preserved by fixation with formalin and analysed histologically by a pathologist. However, current advances in biomedicine make an increased use of sophisticated molecular technologies which, rather than looking at the tissue morphology, analyse changes in specific molecules active in cellular pathways (biomarkers). These technologies require tissue that has not been compromised by the traditional biopsy fixation with formalin. Sorek Medical Systems Ltd. is a 16-year-old R&D company focused on researching, developing and producing high-tech diagnostic medical devices. Sorek's objective in this project is to develop and market a device for breast cancer biopsy which optimizes tissue sample acquisition, handling and preservation. Sorek's innovative solution, unique in the market, solves the problem of sample processing standardization and generates a sample ready for biomarker analysis, among other advantages. Sorek's biopsy devices will be used by radiologists and surgeons, and by pharmaceutical companies seeking the development of biomarker-targeting drugs with the goal of improving cancer diagnostics and the practice of personalized medicine. The innovation is of critical importance to the further development of the company, as it will reinforce its position and help us grow in an area with such huge potential as breast cancer diagnostic devices. The objective of this project is to perform a feasibility study of the technical, commercial, and financial perspectives of Sorek's proprietary differential temperature preservation technology including, among others, analysis of additional RD necessary, certifications and standardizations required by the industry, regulatory environment and patentability, and commercial strategy involving our present and future commercial partners.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "CRYOBIOPSY" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "CRYOBIOPSY" are provided by the European Opendata Portal: CORDIS opendata.